Washington Legislative Update

Jenna Stern, Associate Vice President of Regulatory Affairs & Public Policy, supports Vizient’s government relations, monitors federal regulatory and legislative developments, and helps communicate Vizient’s positions on developments most relevant to Vizient and its members. Prior to joining Vizient, Jenna served as the Director of Health Policy for the American Pharmacists Association and as a senior associate with Avalere, a DC-based healthcare consulting firm.

Jenna received her law degree with a concentration in health law from Case Western Reserve University and is a member of the Maryland bar. She is also a graduate of Brock University where she received her bachelor of science in health sciences.

Jenna Stern, Associate VP of Regulatory Affairs & Public Policy at Vizient provides overview of presentation.
Jenna Stern, Associate VP of Regulatory Affairs & Public Policy at Vizient provides overview of presentation.

LEARNING OBJECTIVES

• Describe actions Congress and the Administration have recently taken related to the pharmaceutical supply chain and drug pricing
• Give examples of steps government agencies have taken given the May 11, 2023 end to the COVID-19 public health emergency
• Discuss anticipated federal legislative and regulatory issues that will impact pharmacists for the year ahead

Latest Videos
View all Videos
Executive Insights
Oct 24, 2024

Ify Igbunike, Director of Pharmacy Services at University of Maryland Midtown Campus, sat down with Pharmacy Angle to discuss value-based pharmacy practices and narcotic diversion prevention. She shares valuable insights on implementing evidence-based care, the role of behavioral assessments in managing controlled substances, and the complexities of regulatory compliance. Watch the full interview to gain expert knowledge on navigating today's healthcare challenges.

Executive Insights
Oct 10, 2024

In this insightful interview, Alex Kardos, Corporate Director of Pharmacy Services at RX Holding Hospital, discusses his role overseeing pharmaceutical operations across 126 sites. He highlights the challenges of navigating regulatory pressures, drug shortages, and staffing issues while emphasizing the growing importance of driving revenue in outpatient settings. Kardos shares how his team balances these demands by leveraging peer insights and vendor partnerships to improve efficiency and compliance.

Executive Insights
Oct 01, 2024

Dr. Rabiah Dys, Senior Vice President of Clinical Services and Program Development at CPS, shared insights at ASHP on her role and passion for advancing health equity. She emphasized the importance of improving health literacy by helping patients understand their diagnoses and care plans, starting at hospital admission. Dr. Dys also highlighted the need for better continuity of care between hospital discharge and community pharmacy settings to ensure patients can manage their health effectively.